Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

Asakawa, A.; Inui, A.; Kaga, T.; Katsuura, G.; Fujimiya, M.; Fujino, M.A.; Kasuga, M.
July 2003
Gut;Jul2003, Vol. 52 Issue 7, p947
Academic Journal
Background and aims: Ghrelin, an endogenous ligand for growth hormone secretagogue receptor (GHS-R), is an appetite stimulatory signal from the stomach with structural resemblance to motilin. We examined the effects of the gastric peptide ghrelin and GHS-R antagonists on energy balance and glycaemic control in mice. Materials and methods: Body weight, fat mass, glucose, insulin, and gene expression of leptin, adiponectin, and resistin in white adipose tissue (WAT) were measured after repeated administrations of ghrelin under a high fat diet. Gastric ghrelin gene expression was assessed by northern blot analysis. Energy intake and gastric emptying were measured after administration of GHS-R antagonists. Repeated administration of GHS-R antagonist was continued for six days in ob/ob obese mice. Results: Ghrelin induced remarkable adiposity and worsened glycaemic control under a high fat diet. Pair feeding inhibited this effect. Ghrelin elevated leptin mRNA expression and reduced resistin mRNA expression. Gastric ghrelin mRNA expression during fasting was increased by a high fat diet. GHS-R antagonists decreased energy intake in lean mice, in mice with diet induced obesity, and in ob/ob obese mice; it also reduced the rate of gastric emptying. Repeated administration of GHS-R antagonist decreased body weight gain and improved glycaemic control in ob/ob obese mice. Conclusions: Ghrelin appears to be closely related to excess weight gain, adiposity, and insulin resistance, particularly under a high fat diet and in the dynamic stage. Gastric peptide ghrelin and GHS-R may be promising therapeutic targets not only for anorexia-cachexia but also for obesity and type 2 diabetes, which are becoming increasingly prevalent worldwide.


Related Articles

  • Pancreatic Exocrine and Endocrine Responses in Chronic Pancreatitis. Anagnostides, A. A.; Cox, T. M.; Adrian, T. E.; Christofides, N. D.; Maton, P. N.; Bloom, S. R.; Chadwick, V. S. // American Journal of Gastroenterology;Mar1984, Vol. 79 Issue 3, p206 

    To test the discriminatory potential of certain indices of pancreatic function we performed duodenal perfusion studies and measured trypsin, bicarbonate, and lactoferrin outputs, and plasma concentrations of pancreatic polypeptide and motilin in the basal state and during continuous intravenous...

  • NMR solution structure and dynamics of motilin in isotropic phospholipid bicellar solution. Andersson, August; Mäler, Lena // Journal of Biomolecular NMR;Oct2002, Vol. 24 Issue 2, p103 

    The structure and dynamics of the gastrointestinal peptide hormone motilin, consisting of 22 amino acid residues, have been studied in the presence of isotropic q=0.5 phospholipid bicelles. The NMR solution structure of the peptide in acidic bicelle solution was determined from 203 NOE-derived...

  • Plasma Ghrelin Concentrations Are Not Regulated by Glucose or Insulin/ A Double-Blind, Placebo-Controlled Crossover Clamp Study. Schaller, Georg; Schmidt, Adele; Pleiner, Johannes; Woloszczuk, Wolfgang; Wolzt, Michael; Woltz, Michael; Luger, Anton // Diabetes;Jan2003, Vol. 52 Issue 1, p16 

    Ghrelin plasma concentrations increase during fasting and fall rapidly after nutrient ingestion. We hypothesized that insulin or glucose could regulate ghrelin secretion by a feedback mechanism. In this randomized, double-blind, placebo-controlled crossover study, three different study days were...

  • Growth Hormone Releasing Peptides.  // Current Medical Literature: GH & Growth Factors;2003, Vol. 18 Issue 1, p20 

    Presents citations and clinicians' notes on growth hormone (GH)-releasing peptides. GH and cortisol rebound rise during and following a somatostatin infusion; Stimulation of GH by Ghrelin; Crystal structure of recombinant fibrinogen fragment D with and without two peptide ligands.

  • Mechanism of interdigestive migrating motor complex in conscious dogs. Nakajima, Hitoshi; Mochiki, Erito; Zietlow, Aaron; Ludwig, Kirk; Takahashi, Toku // Journal of Gastroenterology;May2010, Vol. 45 Issue 5, p506 

    The migrating motor complex (MMC) is well characterized by the appearance of gastrointestinal contractions in the interdigestive state. This study was designed to clarify the mechanisms of gastric MMC (G-MMC) and intestinal MMC (I-MMC) in conscious dogs. Five strain gauge transducers were...

  • Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study. Venkatasubramani, Narayanan; Rudolph, Colin D.; Sood, Manu R. // BMC Gastroenterology;2008, Vol. 8, Special section p1 

    Background: Motilin, a peptide hormone has a direct excitatory effect on circular smooth muscle strips derived from the human colon. Reduced plasma motilin concentration has been reported in adults with chronic constipation. Erythromycin, a non-peptide motilin receptor agonist, induces phase 3...

  • Effect of Atilmotin, a Motilin Receptor Agonist, on Esophageal, Lower Esophageal Sphincter, and Gastric Pressures. Korimilli, Annapurna; Parkman, Henry P. // Digestive Diseases & Sciences;Feb2010, Vol. 55 Issue 2, p300 

    Motilin, an endogenous gastrointestinal (GI) hormone, increases upper gastrointestinal tract motility and is associated with phase III of the gastric migrating motor complex. The motilin receptor agonist, atilmotin, at doses of 6, 30 or 60 μg intravenously (IV), increases the early phase of...

  • Erythromycin: A Motilin Agonist and Gastrointestinal Prokinetic Agent. Weber Jr., Frederick H.; Richards, Robert D.; McCallum, Richard W. // American Journal of Gastroenterology;Apr1993, Vol. 88 Issue 4, p485 

    Erythromycin, a commonly used antibiotic, has recently emerged as a potential gastrointestinal prokinetic agent. This follows a decade of research into the mechanism of well-recognized gastrointestinal side effects of erythromycin. Early investigations demonstrated that erythromycin increased...

  • Motilin.  // Encyclopedic Reference of Molecular Pharmacology;2004, p609 

    The article presents an encyclopedia entry for "motilin." It refers to the 22-amino acid peptide hormone secreted by the enterochromaffin cells of the small intestine, which has a profound effect on gastric motility by inducing contractions of the antrum and duodenum. It acts on a G-protein...


Read the Article


Sign out of this library

Other Topics